Pharmacy, Health Sciences, & Exercise Science
Retrospective Chart Review of Spirometry Utilization in Patients with COPD at Community Health Network
Document Type
Poster Presentation
Location
Indianapolis, IN
Start Date
13-4-2018 8:30 AM
End Date
13-4-2018 10:00 AM
Sponsor
Jessica Wilhoite (Butler University)
Description
The World Health Organization (WHO) estimates that COPD will be ranked as the third leading cause of death in 2030. Pharmacists have the unique opportunity to impact these patients in the outpatient setting as they play an important role in medication and disease state education. The purpose of this study was to evaluate spirometry use in patients with a COPD diagnosis at Community Health Network. A retrospective chart review was conducted on patients seen by an ambulatory care pharmacist between July 1st, 2016 and July 1st, 2017. Data collected included age, smoking history, date of diagnosis, date of spirometry, spirometric measures, mMRC/CAT scores, exacerbation history and current medications. The primary objective of this study was to determine the utilization of spirometry at the time of diagnosis and during treatment in patients with COPD. The secondary objectives were to determine the appropriateness of guideline supported pharmacotherapy in the treatment of COPD and to record the number of years since the last spirometric measure. Patients 18-89 years old without other severe pulmonary diseases such as asthma, cancer, or alpha-1 antitrypsin deficiency were included. Of the 494 patients reviewed 285 were excluded and 209 were included in the data analysis. Fifty-seven percent (n = 120) of patients reviewed had spirometric values documented and ten and a half percent (n = 22) had mMRC or CAT scores recorded. The results identify a potential area of improvement for pharmacists to educate providers on conducting pulmonary function tests for diagnosis. More importantly the pharmacist may be involved in performing symptom assessment questionnaires to determine the appropriate course of therapy.
Retrospective Chart Review of Spirometry Utilization in Patients with COPD at Community Health Network
Indianapolis, IN
The World Health Organization (WHO) estimates that COPD will be ranked as the third leading cause of death in 2030. Pharmacists have the unique opportunity to impact these patients in the outpatient setting as they play an important role in medication and disease state education. The purpose of this study was to evaluate spirometry use in patients with a COPD diagnosis at Community Health Network. A retrospective chart review was conducted on patients seen by an ambulatory care pharmacist between July 1st, 2016 and July 1st, 2017. Data collected included age, smoking history, date of diagnosis, date of spirometry, spirometric measures, mMRC/CAT scores, exacerbation history and current medications. The primary objective of this study was to determine the utilization of spirometry at the time of diagnosis and during treatment in patients with COPD. The secondary objectives were to determine the appropriateness of guideline supported pharmacotherapy in the treatment of COPD and to record the number of years since the last spirometric measure. Patients 18-89 years old without other severe pulmonary diseases such as asthma, cancer, or alpha-1 antitrypsin deficiency were included. Of the 494 patients reviewed 285 were excluded and 209 were included in the data analysis. Fifty-seven percent (n = 120) of patients reviewed had spirometric values documented and ten and a half percent (n = 22) had mMRC or CAT scores recorded. The results identify a potential area of improvement for pharmacists to educate providers on conducting pulmonary function tests for diagnosis. More importantly the pharmacist may be involved in performing symptom assessment questionnaires to determine the appropriate course of therapy.